Estados Unidos
Immune cells infltrating the tumor microenvironment are physiologically important in controlling cancers. However, emerging studies have shown that cancer cells can evade immune surveillance and establish a balance in which these immune cells support tumor progression and therapeutic resistance. The signaling lymphocytic activation molecule family members have been recognized as mediators of tumor microenvironment interactions, and a promising therapeutic target for cancer immunotherapy. This review is focused on the role of SLAM family in tumor and immune cell interactions and discusses how such crosstalk afects tumor behavior. This will shed insight into the next step toward improving cancer immunotherapy.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados